United States · 
Who invested in Jaguar Gene Therapy?
Jaguar Gene Therapy's investors include Goldman Sachs, ARCH Venture Partners, Deerfield and Eli Lilly.
United States · Venture startup
Who invested in Jaguar Gene Therapy
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureMar 2022
- Investors
- 4
The rounds
- Mar 2022
Founders and team
From Jaguar Gene Therapy's own website: 3 on the team.
- Jaguar Gene TherapyChief Executive Officer
- Joe NolanCEO
- Sean P. NolanJaguar Gene Therapy Board of Directors
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Jaguar Gene Therapy as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Jaguar Gene Therapy
How much has Jaguar Gene Therapy raised?
Jaguar Gene Therapy has raised 1 round since 2022, none with a disclosed amount.
When did Jaguar Gene Therapy last raise?
Jaguar Gene Therapy's most recent round was a Venture in Mar 2022.
Who backed Jaguar Gene Therapy first?
Jaguar Gene Therapy's first round on record, in Mar 2022, was backed by Goldman Sachs, ARCH Venture Partners and Deerfield and 1 others.
What stage is Jaguar Gene Therapy at?
Jaguar Gene Therapy's latest named round is a Venture, in Mar 2022.
Where is Jaguar Gene Therapy based?
Jaguar Gene Therapy is based in the United States.
Companies like Jaguar Gene Therapy
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.